Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for reduction of cough after extubation
IRCT20180416039326N19Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine in Cough during extubation (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Cough incidence after extubation, Systolic blood pressure and 4 more. Started Apr 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Cough during extubation
Beyond the preview
Go deeper on IRCT20180416039326N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039326N19.